A study of 30 T2DM patients with known cardiovascular diseases identified that T2DM patients treated with insulin and/or sufonylurea experienced high incidences of hypoglycemia, and were more susceptible to ventricular arrhythmogenesis [244]. This evidence concerns the gene INS and type 2 diabetes mellitus.